Methods and analysis: We will undertake a UK multicentre randomised controlled trial to compare LAO with OO in adult patients with oesophageal cancer. The primary outcome is patient-reported physical function at 3 and 6 weeks post-operatively and 3 months post-randomisation. Secondary outcomes include: post-operative complications, survival, disease recurrence, other measures of quality of life, spirometry, success of patient blinding and quality assurance measures. A cost-effectiveness analysis will be performed comparing LAO with OO. We will embed a randomised IDEAL phase 2b sub-study to evaluate the safety and evolution of the TMIO procedure and a qualitative recruitment intervention to optimise patient recruitment. We will analyse the primary outcome using a multi-level regression model. Patients will be monitored for up to 3 years after their surgery.
Ethics and dissemination: This study received approval from South-West Frenchay Research Ethics Committee. We will submit the results for publication in a peer-reviewed journal.
|Number of pages||8|
|Publication status||Published - 19 Nov 2019|
- BTC (Bristol Trials Centre)
FingerprintDive into the research topics of 'Laparoscopically assisted vs open oesophagectomy for patients with oesophageal cancer – the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) study: protocol for a randomized controlled trial (RCT)'. Together they form a unique fingerprint.
Dr Marcus J Jepson
- Bristol Medical School (PHS) - Senior Lecturer in Qualitative Health Science
- Bristol Population Health Science Institute
- Centre for Academic Primary Care
Person: Academic , Member